Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.

The aims of this study were to compare the pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese individuals and to determine the effect of obesity on the pharmacokinetic properties of oseltamivir and the active antiviral metabolite oseltamivir carboxylate.The population...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Chairat, K, Jittamala, P, Hanpithakpong, W, Day, N, White, N, Pukrittayakamee, S, Tarning, J
التنسيق:	Journal article
اللغة:	English
منشور في:	Wiley 2016

مواد مشابهة

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
حسب: Jittamala, P, وآخرون
منشور في: (2014)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
حسب: Instiaty, I, وآخرون
منشور في: (2013)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
حسب: Jittamala, P, وآخرون
منشور في: (2014)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
حسب: Wattanagoon, Y, وآخرون
منشور في: (2009)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
حسب: Jang K, وآخرون
منشور في: (2017-03-01)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
حسب: Lindegårdh, N, وآخرون
منشور في: (2007)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
حسب: Pukrittayakamee, S, وآخرون
منشور في: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
حسب: Pukrittayakamee, S, وآخرون
منشور في: (2011)

Chemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant rats.
حسب: Chia-Chun Lin, وآخرون
منشور في: (2012-01-01)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
حسب: Seo, S, وآخرون
منشور في: (2013)

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
حسب: Enno D Wildschut, وآخرون
منشور في: (2010-01-01)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
حسب: Chairat, K, وآخرون
منشور في: (2018)

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design.
حسب: Micaela B Reddy, وآخرون
منشور في: (2015-01-01)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
حسب: Rebekah Honce, وآخرون
منشور في: (2023-08-01)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
حسب: Chotsiri, P, وآخرون
منشور في: (2017)

Importance of collection tube during clinical studies of oseltamivir.
حسب: Lindegardh, N, وآخرون
منشور في: (2007)

Ode to Oseltamivir and Amantadine?
حسب: JM Conly, وآخرون
منشور في: (2006-01-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
حسب: Parvaiz A Koul, وآخرون
منشور في: (2024-01-01)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
حسب: Lindegardh, N, وآخرون
منشور في: (2006)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.
حسب: Anekthananon, T, وآخرون
منشور في: (2013)

Impact of Oseltamivir and Diabetes Development
حسب: Bor-Show Tzang, وآخرون
منشور في: (2025-01-01)

Impact of oseltamivir on the risk of cancer
حسب: Pei-Hua Chuang, وآخرون
منشور في: (2024-02-01)

Rapid Emergence of Oseltamivir Resistance
حسب: Cheng Len Sy, وآخرون
منشور في: (2010-04-01)

Assay to Detect Oseltamivir Resistance
حسب: Kamol Suwannakarn, وآخرون
منشور في: (2006-12-01)

Oseltamivir in pregnancy and birth outcomes
حسب: Vera Ehrenstein, وآخرون
منشور في: (2018-10-01)

Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers
حسب: Kyla L. Hooker, وآخرون
منشور في: (2021-03-01)

Pharmacokinetic interactions between primaquine and chloroquine.
حسب: Pukrittayakamee, S, وآخرون
منشور في: (2014)

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks
حسب: Elsa Hansen, وآخرون
منشور في: (2010-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
حسب: A.B. Ivanyuk, وآخرون
منشور في: (2008-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
حسب: A.B. Ivanyuk, وآخرون
منشور في: (2008-01-01)

Oseltamivir and G6PD deficiency
حسب: Şinasi Özsoylu
منشور في: (2010-06-01)

Oseltamivir and G6PD deficiency
حسب: Şinasi Özsoylu
منشور في: (2010-06-01)

Oseltamivir Enhances Hippocampal Network Synchronization
حسب: Atsushi Usami, وآخرون
منشور في: (2008-01-01)

Oseltamivir for the treatment of influenza in children and adolescents
حسب: Alfredo Tagarro, وآخرون
منشور في: (2019-05-01)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
حسب: Renee W. Y. Chan, وآخرون
منشور في: (2022-02-01)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in thai health workers: A randomized, double-blind, placebo-controlled safety trial over 16 weeks. [J Antimicrob Chemother 68, (2013) 697-707]
حسب: Anekthananon, T, وآخرون
منشور في: (2013)

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
حسب: Dennis Morrison, وآخرون
منشور في: (2007-12-01)

Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs’ excretion into the bile and kidney
حسب: Kunio Fujiwara, وآخرون
منشور في: (2020-06-01)

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
حسب: Wang, Y, وآخرون
منشور في: (2019)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
حسب: Tarning, J, وآخرون
منشور في: (2024)